Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

Token-ology: the next thing
Opinion

David Chaplin: Token-ology: the next thing

Despite promising developments, fund tokenisation remains in an experimental phase.

David Chaplin 11 Dec 2024
Covid helped polarise us
Opinion

Sir Peter Gluckman: Covid helped polarise us

The pandemic's consequences continue to reverberate. 

Rangatira eyes international stocks
Opinion

Paul McBeth: Rangatira eyes international stocks

The investment firm is finding things tough going for local holdings.

Paul McBeth 10 Dec 2024
Nabers, everybody needs good Nabers
Property Opinion

Maria Slade: Nabers, everybody needs good Nabers

New Zealand is 15 years behind Australia in encouraging green building.

Maria Slade 09 Dec 2024